Page results
-
What happens after seeing the doctor? Your doctor will decide whether you need any follow up, by telephone or face to face, or whether your results can be communicated to you in a…
-
Publications
-
The department of medical physics and biomedical engineering provides expert physical science support to activities both within UCLH and to a wide range of external partners.
-
What is Cognitive Behavioural Therapy (CBT)? CBT is evidence-based therapy. It involves working with a practitioner collaboratively, to understand the problems that are keeping you stuck, and to…
-
About the RLHIM Pharmacy The RLHIM pharmacy is run by pharmacists who specialise in natural medicines, and it is both a hospital and a retail pharmacy. The RLHIM hospital pharmacy The…
-
Who we are - a community, not just a charity The Friends of UCLH have been supporting UCLH for many years, before that supporting the individual hospitals that came together to form UCLH.…
-
Acupuncture is the insertion of solid needles into the body to improve health. The needles are very fine, much thinner than needles used to give injections or take blood samples. We use sterile needles. They are disposable and never reused.
-
Media statement UCLH chief executive David Probert said: “Many congratulations to Carrie and Boris Johnson on the birth of their baby daughter Romy Iris Charlotte Johnson. We wish…
File results
-
FOI/2023/0007 - Outpatient activity for 2022
-
FOI/2023/0009 - Procedure volumes/ average costs for portable and stable oxygen concentrator devices
-
FOI/2023/0010 - Bardet-biedle Syndrome patient treatment and diagnosis
-
FOI/2023/0013 - Average waiting times for colonoscopy investigations
-
FOI/2023/0014 - Surgery protocols/ standard operating procedures for a feticide
-
FOI/2023/0018 - A&E attendances/ admissions by patients of no fixed abode
-
FOI/2023/0019 - Public access to water refill stations on your premises
-
FOI/2023/0022 - Guidelines staff follow for patients with disabilities and autism
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment